Hormones and Cancer
The main objective of the laboratory is to contribute to the treatment of breast cancer from basic/applied research. We carry out two main lines of work. One of them deals with the effect of stress hormones and different compounds that can improve the treatment of patients and reduce the toxicity of some drugs (especially chemotherapy), thus improving their quality of life. The other line of investigation involves how to resolve cases of resistance to hormone therapy in breast cancer by studying the mechanisms of action of the drugs used and finding novel therapeutic targets.
Research area laboratories
Proteoglycan and Extracellular Matrix Chemistry
Dr. Juan Carlos Calvo
Molecular Oncology and New Therapeutic Targets
Dra. Adriana De Siervi
Nuclear Receptors
Dr. Mario D. Galigniana
Pharmaceutical Biotechnology
Dr. Gustavo Helguera
Hormonal Carcinogenesis
Dra. Claudia Lanari
Hormones and Cancer
Dra. Isabel Alicia Lüthy
Molecular and Functional Glycomics
Dra. Karina V. Mariño
Studies of the Physiopathology of the Ovary
Dra. María Fernanda Parborell
Glycomedicine
Dr. Gabriel Adrian Rabinovich
Tumor Immunology
Dra. Roxana Schillaci
Pathology and Molecular Pharmacology
Dra. Carina Shayo
Tumor Physiology and Biology of the Ovary
Dra. Marta Tesone
Cell-Cell Interaction Studies in Reproduction and Cancer
Dra. Mónica Hebe Vazquez-Levin
Stem Cells
Dr. Norma Alejandra Chasseing / Dr. Juan Carlos Calvo
